Investor mix
13 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 3 | 23% |
| Accelerator & incubator | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 2 | 15% |
Developer of small molecule immuno-oncology drugs
13 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 3 | 23% |
| Accelerator & incubator | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 2 | 15% |